2004•Journal of medical imagingRequires access

Floxuridine-lipiodol emulsion embolization for treatment of hepatic carcinoma

Lijun Zhang

Abstract

Objective:To evaluate the effectiveness of floxuridine-lipiodol emulsion embolization for treatment of hepatic carcinoma.Methods:47 patients with hepatic carcinoma were selected to carry out transcatheter artery chemoembolization (TACE) with floxuridine-lipiodol emulsion. A month after TACE,a repeat CT examination was performed to evaluate the effectiveness.[WT5”HZ]Results:TACE was carried out 133 times (range,1～9 times;mean,2.8 times) in 47 patients,After TACE lipiodol absorption was observed :Grade Ⅰin 24 patients (51%),Grade Ⅱ in 14 (30%),Grade Ⅲ in 9 (19%),post-embolization syndrome was light.No severe complications happened.Conclusion:TACE with floxuridine-lipiodol emulsion is effective and safe for hepatic cacinoma.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Lipiodol, Medicine, Floxuridine, Embolization, Radiology, Carcinoma, Gastroenterology, Nuclear medicine